A Stromal Solution
The Pathologist, January 2018
The tumor-stroma ratio (TSR) could yield more accurate cancer prognoses and improve personalized treatment. The international multicenter UNITED study began in January 2018 to investigate the promise of TSR – but all pathologists are welcome, so why not join the study?
0